NYSE · EHAB

Enhabit, Inc.

$13.80 +$0.01 (+0.07%) 1D

Key Metrics

$474.69M
Market cap
339.07×
P/E · TTM
$4.90M
Revenue · TTM
$1.40M
Net income
EPS · TTM $0.03
Dividend yield
Free cash flow
Beta · 1Y 0.19
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 23
    The stock moved +22.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 23

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$474.69M
Enterprise value$853.29M
Shares outstanding50.6M
52-wk range$6.47 – $14.22
Avg volume · 20D655.3K
Net cash −$378.60M
Book value / share$10.90
IndustryServices-Home Health Care Services
ExchangeNYSE
About Enhabit, Inc.
IPO dateJun 23, 2022
Employees10700

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E339.07
P/S96.88
P/FCF
EV/EBITDA
EV/Sales174.14
Graham №$2.60

Profitability

Gross
Operating -57.1%
Net 28.6%
FCF
ROE / ROIC 0.3% · —

Financial Health

Current ratio1.56
Quick ratio
Debt / equity0.77
Debt / EBITDA
Net cash −$378.60M
Working capital$79.00M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

0.6
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$2.60 vs $13.80
Trades 5.3× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings